Nan Shan Life Insurance’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.1M | Buy |
149,010
+120,454
| +422% | +$33.2M | 0.91% | 34 |
|
|
2025
Q1 | $7.58M | Sell |
28,556
-25,344
| -47% | -$6.72M | 0.18% | 87 |
|
|
2024
Q4 | $12.5M | Buy |
+53,900
| New | +$12.5M | 0.3% | 77 |
|
|
2024
Q3 | – | Sell |
-144,433
| Closed | -$28.4M | – | 101 |
|
|
2024
Q2 | $28.4M | Hold |
144,433
| – | – | 0.67% | 54 |
|
|
2024
Q1 | $31.1M | Buy |
144,433
+54,000
| +60% | +$11.6M | 0.73% | 53 |
|
|
2023
Q4 | $19M | Buy |
90,433
+70,433
| +352% | +$14.8M | 0.46% | 62 |
|
|
2023
Q3 | $4M | Sell |
20,000
-248,290
| -93% | -$49.7M | 0.11% | 85 |
|
|
2023
Q2 | $49.7M | Hold |
268,290
| – | – | 1.2% | 27 |
|
|
2023
Q1 | $51.4M | Buy |
+268,290
| New | +$51.4M | 1.22% | 25 |
|
|
2022
Q1 | – | Sell |
-120,000
| Closed | -$27.4M | – | 90 |
|
|
2021
Q4 | $27.4M | Hold |
120,000
| – | – | 0.42% | 67 |
|
|
2021
Q3 | $23.2M | Sell |
120,000
-62,000
| -34% | -$12M | 0.39% | 69 |
|
|
2021
Q2 | $38.7M | Sell |
182,000
-90,785
| -33% | -$19.3M | 0.66% | 57 |
|
|
2021
Q1 | $55.7M | Buy |
272,785
+174,785
| +178% | +$35.7M | 1.08% | 27 |
|
|
2020
Q4 | $17.8M | Sell |
98,000
-30,000
| -23% | -$5.46M | 0.37% | 78 |
|
|
2020
Q3 | $21.4M | Sell |
128,000
-9,821
| -7% | -$1.64M | 0.56% | 52 |
|
|
2020
Q2 | $22.4M | Sell |
137,821
-15,179
| -10% | -$2.47M | 0.68% | 48 |
|
|
2020
Q1 | $26.5M | Buy |
153,000
+50,000
| +49% | +$8.65M | 0.97% | 34 |
|
|
2019
Q4 | $20.7M | Buy |
103,000
+98,888
| +2,405% | +$19.8M | 0.64% | 40 |
|
|
2019
Q3 | $869K | Buy |
4,112
+1,141
| +38% | +$241K | 0.02% | 85 |
|
|
2019
Q2 | $577K | Sell |
2,971
-2,650
| -47% | -$515K | 0.01% | 91 |
|
|
2019
Q1 | $925K | Buy |
+5,621
| New | +$925K | 0.02% | 102 |
|